| Filed On | Filing |
|---|---|
| 10 Aug 2021 |
8-K/A: Results of Operations and Financial Condition
SILVER SPRING, Md. – August 9, 2021 – Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing... |
Loading...